Integral Health Asset Management, LLC: 13F holdings, Q2 2026
Hedge fund · SEC EDGAR filings (CIK 1773206) · Explore on the interactive board
Integral Health Asset Management, LLC disclosed 89 US equity positions worth $2.4bn in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 14, 2026). Its largest position is RVMD at 11.5% of the reported book, followed by INSM, CYTK. The top ten holdings are 46.5% of the book, and the portfolio behaves like about 29 equal-weight positions. Versus the prior filing it opened 29 new positions, added to 23, reduced 20 and exited 25. Note: this manager's most recent filing is 3934 quarters behind the newest quarter on file, so these figures are history rather than current positioning.
What does Integral Health Asset Management, LLC own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 29 new, 23 added, 20 reduced, 25 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | RVMD REVOLUTION MEDICINES INC | Healthcare | 11.5% | $280.9m | 1,500,000 | 0% | held |
| 2 | INSM INSMED INC | Healthcare | 7.0% | $170.6m | 1,600,000 | 7% | added |
| 3 | CYTK CYTOKINETICS INC | Healthcare | 5.6% | $136.3m | 1,600,000 | 0% | held |
| 4 | CVS CVS HEALTH CORP | Healthcare | 4.7% | $113.8m | 1,100,000 | 633% | added |
| 5 | EWTX EDGEWISE THERAPEUTICS INC | Healthcare | 3.3% | $81.3m | 2,000,000 | 25% | added |
| 6 | VERA VERA THERAPEUTICS INC | Healthcare | 3.1% | $75.1m | 1,750,000 | 9% | added |
| 7 | AXSM AXSOME THERAPEUTICS INC. | Healthcare | 3.0% | $73.4m | 300,000 | 757% | added |
| 8 | CAH CARDINAL HEALTH INC | Healthcare | 2.9% | $71.3m | 300,000 | 11% | added |
| 9 | ROIV ROIVANT SCIENCES LTD | Healthcare | 2.9% | $70.8m | 2,000,000 | 0% | held |
| 10 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 2.5% | $61.1m | 550,000 | -8% | reduced |
| 11 | EW EDWARDS LIFESCIENCES CORP | Healthcare | 2.3% | $56.5m | 625,000 | 268% | added |
| 12 | ALHC ALIGNMENT HEALTHCARE INC | Healthcare | 2.0% | $47.6m | 2,000,000 | -22% | reduced |
| 13 | MRK MERCK & CO INC | Healthcare | 1.8% | $45.0m | 350,000 | -18% | reduced |
| 14 | DGX QUEST DIAGNOSTICS INC | Healthcare | 1.7% | $42.4m | 200,000 | 233% | added |
| 15 | UNIQURE NV | 1.7% | $41.5m | 900,000 | 0% | held | |
| 16 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 1.7% | $41.2m | 750,000 | 50% | added |
| 17 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 1.6% | $38.4m | 900,000 | 64% | added |
| 18 | BTSG BRIGHTSPRING HEALTH SVCS INC | Healthcare | 1.6% | $38.4m | 550,000 | -56% | reduced |
| 19 | ABT ABBOTT LABORATORIES | Healthcare | 1.5% | $36.3m | 400,000 | – | new |
| 20 | UNH UNITEDHEALTH GROUP INC | Healthcare | 1.4% | $35.3m | 85,000 | – | new |
| 21 | LFST LIFESTANCE HEALTH GROUP INC | Healthcare | 1.3% | $32.1m | 3,000,000 | -30% | reduced |
| 22 | NVS NOVARTIS AG | Healthcare | 1.3% | $31.3m | 200,000 | -20% | reduced |
| 23 | TNGX TANGO THERAPEUTICS INC | Healthcare | 1.3% | $31.3m | 1,000,000 | 122% | added |
| 24 | THC TENET HEALTHCARE CORP | Healthcare | 1.3% | $30.9m | 165,000 | – | new |
| 25 | SYRE SPYRE THERAPEUTICS INC | Healthcare | 1.2% | $28.9m | 325,000 | – | new |
| 26 | NVO NOVO-NORDISK A S | Healthcare | 1.2% | $28.8m | 600,000 | – | new |
| 27 | DFTX DEFINIUM THERAPEUTICS INC | Healthcare | 1.1% | $25.9m | 550,000 | 38% | added |
| 28 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 1.0% | $25.3m | 150,000 | 0% | held |
| 29 | REGN REGENERON PHARMACEUTICALS | Healthcare | 1.0% | $24.9m | 40,000 | -53% | reduced |
| 30 | BIIB BIOGEN INC | Healthcare | 0.9% | $21.6m | 100,000 | 67% | added |
| 31 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 0.9% | $21.3m | 375,000 | – | new |
| 32 | LNTH LANTHEUS HLDGS INC | Healthcare | 0.9% | $21.1m | 190,000 | 52% | added |
| 33 | GKOS GLAUKOS CORP | Healthcare | 0.9% | $21.0m | 150,000 | -14% | reduced |
| 34 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 0.8% | $20.6m | 1,900,000 | 36% | added |
| 35 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 0.8% | $20.5m | 275,000 | 0% | held |
| 36 | VRTX VERTEX PHARMACEUTICALS INC | Healthcare | 0.8% | $19.9m | 40,000 | 0% | held |
| 37 | ALMS ALUMIS INC | Healthcare | 0.8% | $19.7m | 700,000 | -12% | reduced |
| 38 | ELV ELEVANCE HEALTH INC FORMERLY | Healthcare | 0.8% | $19.3m | 50,000 | -33% | reduced |
| 39 | CNC CENTENE CORP DEL | Healthcare | 0.8% | $19.3m | 300,000 | -54% | reduced |
| 40 | ERAS ERASCA INC | Healthcare | 0.8% | $18.3m | 1,000,000 | 43% | added |
| 41 | LLY ELI LILLY & CO | Healthcare | 0.7% | $18.0m | 15,000 | 0% | held |
| 42 | ARWR ARROWHEAD PHARMACEUTICALS IN | Healthcare | 0.7% | $16.3m | 200,000 | -33% | reduced |
| 43 | NVST ENVISTA HOLDINGS CORPORATION | Healthcare | 0.6% | $15.8m | 600,000 | 71% | added |
| 44 | MDT MEDTRONIC PLC | Healthcare | 0.6% | $15.6m | 200,000 | – | new |
| 45 | WAT WATERS CORP | Healthcare | 0.6% | $15.0m | 40,000 | – | new |
| 46 | LIVN LIVANOVA PLC | Healthcare | 0.6% | $14.8m | 180,000 | 20% | added |
| 47 | FBRX FORTE BIOSCIENCES INC | 0.6% | $14.3m | 675,000 | 350% | added | |
| 48 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 0.6% | $13.4m | 25,000 | 0% | held |
| 49 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 0.5% | $13.4m | 40,000 | 0% | held |
| 50 | ANRO ALTO NEUROSCIENCE INC | Healthcare | 0.5% | $13.2m | 500,000 | 0% | held |
What did Integral Health Asset Management, LLC sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| AZN ASTRAZENECA PLC | 17.2% | $49.3m |
| ASND ASCENDIS PHARMA A/S | 9.2% | $26.3m |
| FMS FRESENIUS MEDICAL CARE AG | 6.1% | $17.5m |
| ISRG INTUITIVE SURGICAL INC | 5.6% | $16.1m |
| TARS TARSUS PHARMACEUTICALS INC | 4.9% | $14.0m |
| GILD GILEAD SCIENCES INC | 4.9% | $13.9m |
| ELAN ELANCO ANIMAL HEALTH INC | 4.6% | $13.2m |
| DNTH DIANTHUS THERAPEUTICS INC | 4.4% | $12.6m |
| DXCM DEXCOM INC | 3.8% | $11.0m |
| SLNOEUR SOLENO THERAPEUTICS INC | 3.8% | $10.9m |
| IRON DISC MEDICINE INC | 3.8% | $10.9m |
| NRIX NURIX THERAPEUTICS INC | 3.8% | $10.8m |
| COO COOPER COS INC | 3.7% | $10.7m |
| TMO THERMO FISHER SCIENTIFIC INC | 3.4% | $9.8m |
| CELC CELCUITY INC | 3.2% | $9.1m |
| SNDX SYNDAX PHARMACEUTICALS INC | 2.8% | $8.2m |
| VKTX VIKING THERAPEUTICS INC | 2.8% | $8.1m |
| CAPR CAPRICOR THERAPEUTICS INC | 2.1% | $6.1m |
| IQV IQVIA HLDGS INC | 2.1% | $6.0m |
| PTGX PROTAGONIST THERAPEUTICS INC | 1.8% | $5.3m |
| EVMN EVOMMUNE INC | 1.8% | $5.2m |
| ZBH ZIMMER BIOMET HOLDINGS INC | 1.6% | $4.5m |
| IMCR IMMUNOCORE HLDGS PLC | 1.1% | $3.0m |
| MAZE MAZE THERAPEUTICS INC | 1.0% | $3.0m |
| UNCY UNICYCIVE THERAPEUTICS INC | 0.5% | $1.5m |
Sector mix
| Sector | Weight |
|---|---|
| Healthcare | 96.0% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
How concentrated is Integral Health Asset Management, LLC's portfolio?
Across every quarter Integral Health Asset Management, LLC has filed, its median largest position is 12.3% of the book and its median top-ten weight is 47.0%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 25.0 completed holding spells, the median lasted 1.0 quarters; 89.0 positions are still open and their final length is unknown.